
    
      The investigators will randomize 180 PAD patients that undergoing a revascularization
      operation in two groups: (1) an endovascular procedure or (2) an open bypass procedure. They
      are also planning to recruit 50 non-PAD healthy control subjects.

      The goal is to answer the main hypothesis that miR-210 gene expression is a master regulator
      of oxidative stress and is associated with mitochondrial dysfunction, oxidative metabolism,
      walking function and quality of life.
    
  